Benzinga | May 5, 2021 07:08AM EDT

Horizon Therapeutics Q1 Adj. EPS $0.03 Misses $0.04 Estimate, Sales $342.40M Beat $330.73M Estimate; Raises FY21 Sales Guidance

Horizon Therapeutics (NASDAQ:HZNP) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.04 by 25 percent. This is a 92.5 percent decrease over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $342.40 million which beat the analyst consensus estimate of $330.73 million by 3.53 percent. This is a 3.80 percent decrease over sales of $355.91 million the same period last year.